Thermo Fisher Scientific Inc. launched new software, instruments, consumables, and services for analytical applications at Pittcon 2013.
Thermo Fisher Scientific launched new software, instruments, consumables, and services for analytical applications at Pittcon 2013.
Thermo Scientific Chromeleon ver. 7.2 chromatography data systems software, supports Thermo Scientific mass spectrometers and allows instruments to be integrated on enterprise-wide networks.
The Thermo Scientific Nicolet iS50 spectrometer can be upgraded from a FT-IR system to multi-range device capable of ATR, Raman, and NIR analysis without manually changing components.
The Thermo Scientific Dionex UltiMate 3000 Biocompatible Rapid Separation (BioRS) system, combines ultra-high performance liquid chromatography (UHPLC) with a corrosion-resistant flow path that can withstand high salt or extreme pH conditions.
The Thermo Scientific Dionex GlycanPac AXH-1 HPLC column allows for better analysis of glycans.
The iCAP 7000 family of inductively coupled plasma-optical emission spectrometers (ICP-OES) feature a high-resolution charged injection device (CID) imager.
The Thermo Scientific PicoSpin-45 spectrometer is a miniature NMR spectrometer designed for applied analysis in laboratories of any size.
Unity Lab SmartCapture Asset Utilization Monitoring provides automated support, service and maintenance, regardless of the instrument manufacturer.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.